4//SEC Filing
LARANJEIRA CHARLES ANTHONY 4
Accession 0001209191-21-066795
CIK 0001396814other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:25 PM ET
Size
7.6 KB
Accession
0001209191-21-066795
Insider Transaction Report
Form 4
LARANJEIRA CHARLES ANTHONY
SVP, Technical Operations
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-11-22−7,500→ 0 totalExercise: $44.10Exp: 2027-06-02→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2021-11-22$44.10/sh+7,500$330,750→ 33,602 total
Footnotes (2)
- [F1]Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.
- [F2]The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001524338
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 4:25 PM ET
- Size
- 7.6 KB